Home / Resource Library / PRIMARY ANALYSIS OF THE PHASE 2 ELM-2 STUDY: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMAPRIMARY ANALYSIS OF THE PHASE 2 ELM-2 STUDY: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA EHA 2024